<DOC>
	<DOCNO>NCT00209950</DOCNO>
	<brief_summary>To evaluate safety tolerability gaboxadol primary insomnia</brief_summary>
	<brief_title>A Prospective Open-Label Extension Study Gaboxadol Primary Insomnia</brief_title>
	<detailed_description>To evaluate long-term safety gaboxadol healthy adult .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>patient diagnosis primary insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Primary insomnia</keyword>
</DOC>